Eli Lilly Net Income 2010-2024 | LLY

Eli Lilly net income for the twelve months ending June 30, 2024 was $7.342B, a 13% increase year-over-year.

  • Eli Lilly annual net income for 2023 was $5.24B, a 16.08% decline from 2022.
  • Eli Lilly annual net income for 2022 was $6.245B, a 11.88% increase from 2021.
  • Eli Lilly annual net income for 2021 was $5.582B, a 9.88% decline from 2020.

Eli Lilly Net Income 2010-2024 | LLY

  • Eli Lilly annual net income for 2023 was $5.24B, a 16.08% decline from 2022.
  • Eli Lilly annual net income for 2022 was $6.245B, a 11.88% increase from 2021.
  • Eli Lilly annual net income for 2021 was $5.582B, a 9.88% decline from 2020.
Related Stocks
Company NameMarket
Cap
Johnson & Johnson (JNJ)$450.1B
Novo Nordisk (NVO)$424.5B
Merck (MRK)$270B
AbbVie (ABBV)$264.1B
AstraZeneca (AZN)$218.5B
Novartis AG (NVS)$218.4B
Pfizer (PFE)$201.2B
Sanofi (SNY)$133B
Innoviva (INVA)$953M